Efficacy and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Janne, P. A.; Baik, C. S.; Su, W. C.; Johnson, M. L.; Hayashi, H.; Nishio, M.; Kim, D. W.; Koczywas, M.; Gold, K. A.; Steuer, C. E.; Murakami, H.; Yang, J. C. H.; Kim, S. W.; Vigliotti, M.; Qi, Z.; Qiu, Y.; Zhao, L.; Sternberg, D. W.; Yu, C.; Yu, H. A. |
| Abstract Title: | Efficacy and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120604301 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.9007 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9007 -- Source: Wos |
